CN101941907A - 4-叔丁基苄基-3,4-二羟基肉桂酸酯及其用途和制备方法 - Google Patents
4-叔丁基苄基-3,4-二羟基肉桂酸酯及其用途和制备方法 Download PDFInfo
- Publication number
- CN101941907A CN101941907A CN2010102097516A CN201010209751A CN101941907A CN 101941907 A CN101941907 A CN 101941907A CN 2010102097516 A CN2010102097516 A CN 2010102097516A CN 201010209751 A CN201010209751 A CN 201010209751A CN 101941907 A CN101941907 A CN 101941907A
- Authority
- CN
- China
- Prior art keywords
- preparation
- formula
- compound shown
- tertiary butyl
- acid ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- -1 4-tertiary butyl benzyl-3,4-dihydroxycinnamic acid ester Chemical class 0.000 title abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 31
- 201000010099 disease Diseases 0.000 claims abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 230000003961 neuronal insult Effects 0.000 claims abstract description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 6
- 239000012074 organic phase Substances 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- 238000003810 ethyl acetate extraction Methods 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 238000001953 recrystallisation Methods 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 229910002027 silica gel Inorganic materials 0.000 claims description 4
- 239000000741 silica gel Substances 0.000 claims description 4
- 229960001866 silicon dioxide Drugs 0.000 claims description 4
- 235000017550 sodium carbonate Nutrition 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 230000000324 neuroprotective effect Effects 0.000 abstract description 7
- 239000002253 acid Substances 0.000 abstract description 4
- 239000000825 pharmaceutical preparation Substances 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 12
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 9
- WWVKQTNONPWVEL-UHFFFAOYSA-N caffeic acid phenethyl ester Natural products C1=C(O)C(O)=CC=C1C=CC(=O)OCC1=CC=CC=C1 WWVKQTNONPWVEL-UHFFFAOYSA-N 0.000 description 8
- SWUARLUWKZWEBQ-UHFFFAOYSA-N phenylethyl ester of caffeic acid Natural products C1=C(O)C(O)=CC=C1C=CC(=O)OCCC1=CC=CC=C1 SWUARLUWKZWEBQ-UHFFFAOYSA-N 0.000 description 8
- DIVDFFZHCJEHGG-UHFFFAOYSA-N oxidopamine Chemical compound NCCC1=CC(O)=C(O)C=C1O DIVDFFZHCJEHGG-UHFFFAOYSA-N 0.000 description 7
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000012930 cell culture fluid Substances 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000016273 neuron death Effects 0.000 description 4
- 230000000452 restraining effect Effects 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 229960002989 glutamic acid Drugs 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 210000001259 mesencephalon Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 101710138657 Neurotoxin Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229940049906 glutamate Drugs 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- UJKDYMOBUGTJLZ-RUCXOUQFSA-N ksc605q1h Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CCC(O)=O UJKDYMOBUGTJLZ-RUCXOUQFSA-N 0.000 description 2
- 239000002581 neurotoxin Substances 0.000 description 2
- 231100000618 neurotoxin Toxicity 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- CTENFNNZBMHDDG-UHFFFAOYSA-N Dopamine hydrochloride Chemical compound Cl.NCCC1=CC=C(O)C(O)=C1 CTENFNNZBMHDDG-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Images
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010209751.6A CN101941907B (zh) | 2010-05-28 | 2010-06-25 | 4-叔丁基苄基-3,4-二羟基肉桂酸酯及其用途和制备方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101859476 | 2010-05-28 | ||
CN201010185947.6 | 2010-05-28 | ||
CN201010185947 | 2010-05-28 | ||
CN201010209751.6A CN101941907B (zh) | 2010-05-28 | 2010-06-25 | 4-叔丁基苄基-3,4-二羟基肉桂酸酯及其用途和制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101941907A true CN101941907A (zh) | 2011-01-12 |
CN101941907B CN101941907B (zh) | 2015-04-01 |
Family
ID=43434146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010209751.6A Active CN101941907B (zh) | 2010-05-28 | 2010-06-25 | 4-叔丁基苄基-3,4-二羟基肉桂酸酯及其用途和制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101941907B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105732405A (zh) * | 2016-04-01 | 2016-07-06 | 南阳师范学院 | 一种4-胺烷氧基-3-甲氧基肉桂酸酯类化合物、制备方法及其用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1589137A (zh) * | 2001-12-10 | 2005-03-02 | 杜燕生 | 神经退化性及心血管疾病之治疗方法 |
-
2010
- 2010-06-25 CN CN201010209751.6A patent/CN101941907B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1589137A (zh) * | 2001-12-10 | 2005-03-02 | 杜燕生 | 神经退化性及心血管疾病之治疗方法 |
Non-Patent Citations (2)
Title |
---|
《合成化学》 20041231 夏春年等 天然抗癌药--咖啡酸苯乙醇酯的合成进展 545-550 3-12 第12卷, 第6期 * |
夏春年等: "天然抗癌药——咖啡酸苯乙醇酯的合成进展", 《合成化学》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105732405A (zh) * | 2016-04-01 | 2016-07-06 | 南阳师范学院 | 一种4-胺烷氧基-3-甲氧基肉桂酸酯类化合物、制备方法及其用途 |
CN105732405B (zh) * | 2016-04-01 | 2018-08-24 | 南阳师范学院 | 一种4-胺烷氧基-3-甲氧基肉桂酸酯类化合物、制备方法及其用途 |
Also Published As
Publication number | Publication date |
---|---|
CN101941907B (zh) | 2015-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102584795B (zh) | 一种克里唑替尼的制备方法 | |
CN102127005B (zh) | 阿维莫潘的中间体及其合成方法 | |
CN104356146B (zh) | 一种头孢替安盐酸盐的制备方法 | |
CN103044402A (zh) | 埃索美拉唑钠合成生产方法 | |
CN108191688A (zh) | 一种合成及结晶d-泛酸钙的方法 | |
CN110791538A (zh) | 一种适用于酶法合成磷酸西格列汀的生产方法 | |
CN103570702A (zh) | 一种适合工业化制备雷替曲塞的方法及适于药用的新晶型 | |
CN105566215A (zh) | 一种瑞戈非尼的制备方法 | |
CN111138443B (zh) | 一种4’-去甲基表鬼臼毒素全合成的制备方法 | |
CN101407513A (zh) | 一种核苷类似物的合成方法 | |
CN102718829A (zh) | 牛磺熊去氧胆酸钠的制备方法 | |
CN105541801B (zh) | Ezh2甲基转移酶抑制剂gsk126的合成方法 | |
CN101941907A (zh) | 4-叔丁基苄基-3,4-二羟基肉桂酸酯及其用途和制备方法 | |
CN104086463B (zh) | 一种1,4-丁二磺酸精品及其溶液的制备方法 | |
CN107879979A (zh) | 一种右美托咪定的制备方法 | |
CN103275010A (zh) | 一种1-(3-甲基-1-苯基-1h-吡唑-5-基)哌嗪的制备方法 | |
CN103755577B (zh) | 一种从盐酸氨溴索精制母液中回收氨溴索碱的方法 | |
CN103193776A (zh) | 一种具有抗肿瘤疗效的新型萘啶衍生物的合成方法 | |
CN104418810A (zh) | 一种左西孟旦的合成新路线 | |
CN100412049C (zh) | 生产二甲酸钾的方法 | |
CN102093254B (zh) | 一种二水合3-(2,2,2-三甲基肼)丙酸盐的制备方法 | |
CN1453278A (zh) | 一种拉唑类化合物及其制备方法与应用 | |
BRPI0517810A (pt) | composto e respectivo método de produção e processo de preparação de 13-deoxiantraciclinas e de 5-imino-13-deoxiantraciclinas | |
CN104151216B (zh) | 一种拉帕替尼侧链的合成方法 | |
CN101531661B (zh) | 四氢叶酸的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: NANJING AIPIKA BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: PAEDIE AG Effective date: 20121217 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; TO: 210009 NANJING, JIANGSU PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20121217 Address after: 01, building 5, Metro 69, 210009 Olympic Sports Avenue, Jianye District, Jiangsu, Nanjing Applicant after: NANJING AIPIKA BIOLOGICAL SCIENCE & TECHNOLOGY CO., LTD. Address before: indiana Applicant before: Pardi Inc. |
|
ASS | Succession or assignment of patent right |
Owner name: MAO TENGSHU Free format text: FORMER OWNER: NANJING AIPIKA BIOTECHNOLOGY CO., LTD. Effective date: 20131217 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 210009 NANJING, JIANGSU PROVINCE TO: 100096 HAIDIAN, BEIJING |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20131217 Address after: 100096 Beijing Haidian District City Garden 68 Building No. 305, producing up new Applicant after: Mao Tengshu Address before: 01, building 5, Metro 69, 210009 Olympic Sports Avenue, Jianye District, Jiangsu, Nanjing Applicant before: NANJING AIPIKA BIOLOGICAL SCIENCE & TECHNOLOGY CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160725 Address after: 100102 Beijing city Chaoyang District Dongyuan Wangjing No. 523 building 13 layer 11610 Patentee after: Beijing pulse Medical Technology Co., Ltd. Address before: 100096 Beijing Haidian District City Garden 68 Building No. 305, producing up new Patentee before: Mao Tengshu |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180327 Address after: 100096 Beijing Haidian District City Garden 68 Building No. 305, producing up new Patentee after: Mao Tengshu Address before: 100102 Beijing city Chaoyang District Dongyuan Wangjing No. 523 building 13 layer 11610 Patentee before: Beijing pulse Medical Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180608 Address after: 100102 13 floor 11610, Wangjing East Garden 523, Chaoyang District, Beijing. Patentee after: Beijing pulse Medical Technology Co., Ltd. Address before: 100096 305, 68 / F, new West Garden, Haidian District, Beijing. Patentee before: Mao Tengshu |